Betaseron
Payments companies reported to CMS as associated with Betaseron. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Betaseron, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Betaseron
These are the largest totals companies reported as associated with Betaseron. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Dakshesh Patel | West Long Branch, NJ | $24.91 | |
| Anthony Izzo | Worcester, MA | Neurology (Psychiatry & Neurology) | $20.81 |
| Justin Donaghy | Worcester, MA | Neurology (Psychiatry & Neurology) | $20.81 |
| Bradley Dekorte | Medford, OR | Sleep Medicine (Family Medicine) | $20.81 |
| Mayer Hasbani | New Haven, CT | Clinical Neurophysiology | $20.56 |
| Jennifer Buckingham | Lumberton, NJ | Family | $19.42 |
| Mayank Mathur | Lumberton, NJ | Neurology (Psychiatry & Neurology) | $19.42 |
Prescribed Betaseron?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.